JPRN-jRCT2072230083尚未招募2 期
Safety confirmation study with dMD-003- Study to evaluate the safety of dMD-003 in patients scheduled to undergo uterine myomectomy
Aihara Fumiaki0 个研究点目标入组 30 人开始时间: 2023年11月7日最近更新:
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 ot applicable（—）
- 性别
- Female
入选标准
- •(1) Patients scheduled to undergo laparoscopic, laparoscopy-assisted, or open uterine myomectomy.
- •Other criteria.
排除标准
- •(1) Patients who have undergone surgery in the abdominal or pelvic cavity (excluding surgery for appendicitis).
- •(2) Patients with concurrent active pelvic inflammatory disease or peritonitis.
- •(3) Patients suspected of having moderate (stage III) or severe endometriosis according to the r-ASRM classification.
- •Other criteria.
研究者
相似试验
已完成
4 期
A clinical trial to study the effects of drug in pediatric subjects with complicated Skin & skin structure infection caused by Gram-positive PathogensCTRI/2009/091/000725Cubist Pharmaceuticals150
未知
1 期
Phase I study of DS-7113bHealthy volunteersJPRN-jRCT2080222121DAIICHISANKYO Co.,Ltd.30
进行中（未招募）
1 期
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Vaccine-Experienced AdultsEUCTR2021-006679-41-ITMERCK SHARP & DOHME LLC. UNA SUSSIDIARIA DI MERCK & CO. INC.700
已完成
3 期
Safety and Immunogenicity of V116 in Vaccine-Experienced AdultsPneumococcal infection preventionJPRN-jRCT2071220025Tanaka Yoshiyuki63
进行中（未招募）
1 期
A Study to Evaluate the Safety, Tolerability, and Immunogenicity of V116 in Vaccine-Experienced AdultsPneumococcal diseaseMedDRA version: 20.0Level: LLTClassification code 10035644Term: Pneumococcal infection NOSSystem Organ Class: 100000004862EUCTR2021-006679-41-ESMerck Sharp & Dohme LLC700